Literature DB >> 20558698

Medicine. HDL miR-ed down by SREBP introns.

Michael S Brown1, Jin Ye, Joseph L Goldstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20558698      PMCID： PMC2936826          DOI： 10.1126/science.1192409

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  11 in total

Review 1.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.

Authors:  Jay D Horton; Joseph L Goldstein; Michael S Brown
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta.

Authors:  J J Repa; G Liang; J Ou; Y Bashmakov; J M Lobaccaro; I Shimomura; B Shan; M S Brown; J L Goldstein; D J Mangelsdorf
Journal:  Genes Dev       Date:  2000-11-15       Impact factor: 11.361

3.  Fatty acid auxotrophy in Drosophila larvae lacking SREBP.

Authors:  Amit S Kunte; Krista A Matthews; Robert B Rawson
Journal:  Cell Metab       Date:  2006-06       Impact factor: 27.287

4.  Why Syndrome X? From Harold Himsworth to the insulin resistance syndrome.

Authors:  Gerald M Reaven
Journal:  Cell Metab       Date:  2005-01       Impact factor: 27.287

Review 5.  The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.

Authors:  M S Brown; J L Goldstein
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

6.  Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells.

Authors:  I Shimomura; H Shimano; J D Horton; J L Goldstein; M S Brown
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

7.  MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis.

Authors:  S Hani Najafi-Shoushtari; Fjoralba Kristo; Yingxia Li; Toshi Shioda; David E Cohen; Robert E Gerszten; Anders M Näär
Journal:  Science       Date:  2010-05-13       Impact factor: 47.728

8.  MiR-33 contributes to the regulation of cholesterol homeostasis.

Authors:  Katey J Rayner; Yajaira Suárez; Alberto Dávalos; Saj Parathath; Michael L Fitzgerald; Norimasa Tamehiro; Edward A Fisher; Kathryn J Moore; Carlos Fernández-Hernando
Journal:  Science       Date:  2010-05-13       Impact factor: 47.728

Review 9.  ABCA1: at the nexus of cholesterol, HDL and atherosclerosis.

Authors:  Alan D Attie
Journal:  Trends Biochem Sci       Date:  2007-02-26       Impact factor: 13.807

10.  Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver.

Authors:  Guoxun Chen; Guosheng Liang; Jiafu Ou; Joseph L Goldstein; Michael S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-20       Impact factor: 11.205
View more
  22 in total

Review 1.  miRNAs: roles and clinical applications in vascular disease.

Authors:  Md Saha Jamaluddin; Sarah M Weakley; Lidong Zhang; Panagiotis Kougias; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  Expert Rev Mol Diagn       Date:  2011-01       Impact factor: 5.225

Review 2.  MicroRNA control of high-density lipoprotein metabolism and function.

Authors:  Katey J Rayner; Kathryn J Moore
Journal:  Circ Res       Date:  2014-01-03       Impact factor: 17.367

3.  Increased expression of miR-33a in monocytes from Mexican hypertensive patients in elevated carotid intima-media thickness.

Authors:  Yazmín Estela Torres-Paz; Claudia Huesca-Gómez; Fausto Sánchez-Muñoz; Rocío Martínez-Alvarado; Ma Elena Soto; Margarita Torres-Tamayo; Giovanny Fuentevilla-Álvarez; Ricardo Gamboa
Journal:  J Hum Hypertens       Date:  2018-09-19       Impact factor: 3.012

Review 4.  From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport.

Authors:  Alberto Dávalos; Carlos Fernández-Hernando
Journal:  Pharmacol Res       Date:  2013-02-19       Impact factor: 7.658

5.  miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling.

Authors:  Alberto Dávalos; Leigh Goedeke; Peter Smibert; Cristina M Ramírez; Nikhil P Warrier; Ursula Andreo; Daniel Cirera-Salinas; Katey Rayner; Uthra Suresh; José Carlos Pastor-Pareja; Enric Esplugues; Edward A Fisher; Luiz O F Penalva; Kathryn J Moore; Yajaira Suárez; Eric C Lai; Carlos Fernández-Hernando
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

Review 6.  MicroRNAs in metabolism and metabolic disorders.

Authors:  Veerle Rottiers; Anders M Näär
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-22       Impact factor: 94.444

7.  MicroRNAs in metabolism and metabolic diseases.

Authors:  V Rottiers; S H Najafi-Shoushtari; F Kristo; S Gurumurthy; L Zhong; Y Li; D E Cohen; R E Gerszten; N Bardeesy; R Mostoslavsky; A M Näär
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-12-12

Review 8.  SREBPs in Lipid Metabolism, Insulin Signaling, and Beyond.

Authors:  Russell A DeBose-Boyd; Jin Ye
Journal:  Trends Biochem Sci       Date:  2018-02-27       Impact factor: 13.807

9.  Anti-atherosclerosis or No Anti-atherosclerosis: That is the miR-33 question.

Authors:  Anders M Näär
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03       Impact factor: 8.311

Review 10.  Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.

Authors:  Vivette D D'Agati; Avry Chagnac; Aiko P J de Vries; Moshe Levi; Esteban Porrini; Michal Herman-Edelstein; Manuel Praga
Journal:  Nat Rev Nephrol       Date:  2016-06-06       Impact factor: 28.314
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.